The atherogenic index of plasma is increased by hormonal contraception
| Authors | |
|---|---|
| Year of publication | 2011 |
| Type | Article in Periodical |
| Magazine / Source | SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION |
| MU Faculty or unit | |
| Citation | |
| Doi | http://dx.doi.org/10.3109/00365513.2011.553240 |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | Oral contraceptives; dyslipidemias; cardiovascular diseases; risk factors; HDL cholesterol; triglycerides; C-reactive protein |
| Description | The aim of this study was to determine if hormonal contraceptives affect the new atherogenic index of plasma (AIP) = log[triglycerides (TG)/high-density lipoprotein cholesterol (HDL-C)] together with the total cholesterol/HDL-C (TC/HDL-C) and the apolipoprotein B/apolipoprotein A1 (apoB/apoA1) ratios. The increased AIP and hs-CRP concentration after 9 months of hormonal contraception demonstrate that contraceptive-induced dyslipidemia has a proatherogenic nature, even when the TC/HDL-C and the apoB/apoA1 ratios are unchanged. |
| Related projects: |